NO914468L - Anvendelse av melatoninderivater for prevensjon - Google Patents

Anvendelse av melatoninderivater for prevensjon

Info

Publication number
NO914468L
NO914468L NO91914468A NO914468A NO914468L NO 914468 L NO914468 L NO 914468L NO 91914468 A NO91914468 A NO 91914468A NO 914468 A NO914468 A NO 914468A NO 914468 L NO914468 L NO 914468L
Authority
NO
Norway
Prior art keywords
ingrediates
melaton
prevention
melaton ingrediates
Prior art date
Application number
NO91914468A
Other languages
English (en)
Other versions
NO914468D0 (no
Inventor
Michael Cohen
Original Assignee
Applied Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/NL1990/000073 external-priority patent/WO1990014084A1/en
Application filed by Applied Med Res filed Critical Applied Med Res
Publication of NO914468D0 publication Critical patent/NO914468D0/no
Publication of NO914468L publication Critical patent/NO914468L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
NO91914468A 1989-05-17 1991-11-14 Anvendelse av melatoninderivater for prevensjon NO914468L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35301989A 1989-05-17 1989-05-17
PCT/NL1990/000073 WO1990014084A1 (en) 1989-05-17 1990-05-17 Use of melatonin derivatives for effecting contraception

Publications (2)

Publication Number Publication Date
NO914468D0 NO914468D0 (no) 1991-11-14
NO914468L true NO914468L (no) 1992-01-07

Family

ID=26646635

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91914468A NO914468L (no) 1989-05-17 1991-11-14 Anvendelse av melatoninderivater for prevensjon

Country Status (3)

Country Link
AU (1) AU644367B2 (no)
BR (1) BR9007382A (no)
NO (1) NO914468L (no)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA88498B (en) * 1987-02-02 1989-10-25 Lilly Co Eli Alkylmelatonins
US4855305A (en) * 1987-03-23 1989-08-08 Applied Medical Research Compositions and methods of effecting contraception utilizing melatonin
KR910006124B1 (ko) * 1987-08-17 1991-08-13 넬슨 리써취 앤드 디벨럽먼트 캄파니 멜라토닌 동족체

Also Published As

Publication number Publication date
BR9007382A (pt) 1992-04-28
NO914468D0 (no) 1991-11-14
AU644367B2 (en) 1993-12-09
AU5720690A (en) 1990-12-18

Similar Documents

Publication Publication Date Title
FI945441A0 (fi) Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi
NO914666L (no) Fjerning av trialkylarsiner
FI903558A0 (fi) Avskiljningsanordning foer avskiljning av antigener.
BR8900004A (pt) Composicoes herbicidas de compostos de heterociclicos-alcoilenos de quinoxaliniloxifenoxipropanoato
NO171058C (no) Syntese av hydrokarbylaminer
MX9100998A (es) Novedosos inhibidores de escualen sintetasa
NO930574L (no) Fremgangsmaate for fremstilling av desfluran
NO932860D0 (no) Fremgangsmaate for fremstilling av kalsium-l-askorbat-2-fosfat
NO920049D0 (no) Fremgangsmaate for fremstilling av 3-eksometylencefamsulfoksydestere
NO940190D0 (no) Anvendelse av x-ketoglutarat
NO920983D0 (no) Fremgangsmaate for behandling av nevrodegenerative tilstander
MX9102079A (es) Plemezcla de semduramicina
KR900015532U (ko) 일부인
NO173871C (no) Fremgangsmaate for fremstilling av penemforbindelser
NO931399D0 (no) Anvendelse av naturstein
FI923360A (fi) Foerfarande foer framstaellning av dimetylacetoacetamid
NO914468L (no) Anvendelse av melatoninderivater for prevensjon
NO903429D0 (no) Konstruksjon for beskyttelse av broennhode.
FI943660A0 (fi) Menetelmä 3-karbonyyliandrostadieeni-17-karboksamidien valmistamiseksi
IT9020793A0 (it) inibizione
IT8847653A0 (it) Sizzante comprendente 5 - idroscomposizione farmaceutica anoressitrpofano
KR900015545U (ko) 화일의 지철구
KR930026760U (ko) Tvcr의 개선된 구성
SE8800420D0 (sv) Lokalisering av foremal
NO930481L (no) Fremgangsmaate for fremstilling av klormetaner